Patient engagement has shifted from a “nice to have” to a strategic necessity.

With regulators expecting defensible evidence, executives demanding clear ROI, and funding under tighter scrutiny, every engagement initiative must show measurable value. Yet many organizations still struggle to demonstrate the true impact of their work.

The 3rd Measuring Patient Engagement Summit is the only event dedicated entirely to transforming patient engagement into credible, quantifiable outcomes. Over three days, more than 70 senior leaders from pharma, biotech, and patient advocacy will come together to share frameworks, tools, and real-world approaches that prove how patient insights drive results across development, access, and commercialization.

Through interactive workshops, case studies, and collaborative sessions, attendees will:

• Shift from anecdotal reporting to robust, outcome-based evidence
• Benchmark strategies, co-develop frameworks, and measure impact across multi-year programs
• Translate engagement activities into meaningful influence for regulators, executives, and patient communities
• Walk away with peer-tested methods, practical tools, and actionable insights to elevate engagement from activity to strategic value

Measuring activity isn’t enough anymore – demonstrating impact is what moves the industry forward.

This summit offers a unique non-competitive environment where you can benchmark your approaches, collaborate directly with peers, and gain practical tools to clearly demonstrate the value of patient engagement. For teams facing tighter budgets, heightened scrutiny, and rising expectations from stakeholders, it’s the essential gathering to shift from anecdotal stories to evidence-backed impact, and to elevate patient‑centric initiatives into strategic, measurable drivers of organizational success.

To know more visit: https://ter.li/8hkio4